Neurosense Therapeutics Ltd (NRSN) is lower by Tuesday morning, with the stock losing -5.21% in pre-market trading to 2. NRSN's short-term technical score of 61 indicates that the stock has traded more bullishly over the last month than 61% of stocks on the market. In the Biotechnology industry, which ranks 90 out of 146 industries, NRSN ranks higher than 70% of stocks. Neurosense Therapeutics Ltd has risen 64.84% over the past month, closing at $1.28 on February 6. During this period of time, the stock fell as low as $1.25 and as high as $2.33. NRSN has an average analyst recommendation of Strong Buy. The company has an average price target of $5.25.
NRSN has an Overall Score of 80. Find out what this means to you and get the rest of the rankings on NRSN!